SCHMIDT ERIC THOMAS 4
4 · Allogene Therapeutics, Inc. · Filed Mar 30, 2021
Insider Transaction Report
Form 4
SCHMIDT ERIC THOMAS
Chief Financial Officer
Transactions
- Award
Common Stock
2021-03-26+24,866→ 96,097 total - Award
Stock Option (Right to Buy)
2021-03-26+92,365→ 92,365 totalExercise: $33.78Exp: 2031-03-26→ Common Stock (92,365 underlying)
Holdings
- 1,152,595(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
- [F2]25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.